RU2011140477A - Пептид профилактического или терапевтического лечения опухолей кожи на начальных стадиях - Google Patents
Пептид профилактического или терапевтического лечения опухолей кожи на начальных стадиях Download PDFInfo
- Publication number
- RU2011140477A RU2011140477A RU2011140477/10A RU2011140477A RU2011140477A RU 2011140477 A RU2011140477 A RU 2011140477A RU 2011140477/10 A RU2011140477/10 A RU 2011140477/10A RU 2011140477 A RU2011140477 A RU 2011140477A RU 2011140477 A RU2011140477 A RU 2011140477A
- Authority
- RU
- Russia
- Prior art keywords
- peptide
- therapeutic treatment
- prophylactic
- skin tumors
- skin
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract 13
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000003449 preventive effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 16
- 230000000069 prophylactic effect Effects 0.000 claims abstract 12
- 206010029098 Neoplasm skin Diseases 0.000 claims abstract 8
- 208000000453 Skin Neoplasms Diseases 0.000 claims abstract 8
- 239000003814 drug Substances 0.000 claims abstract 6
- 238000004519 manufacturing process Methods 0.000 claims abstract 6
- 201000009030 Carcinoma Diseases 0.000 claims abstract 4
- 208000009621 actinic keratosis Diseases 0.000 claims abstract 4
- 230000015572 biosynthetic process Effects 0.000 claims abstract 4
- 239000003112 inhibitor Substances 0.000 claims abstract 4
- 201000010153 skin papilloma Diseases 0.000 claims abstract 4
- 241000124008 Mammalia Species 0.000 claims abstract 2
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims abstract 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims abstract 2
- 239000003085 diluting agent Substances 0.000 claims abstract 2
- 230000002401 inhibitory effect Effects 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200900694 | 2009-03-06 | ||
| ES200900694A ES2347627B1 (es) | 2009-03-06 | 2009-03-06 | Peptido para el tratamiento profilactico o terapeutico de tumores de la piel en estadios iniciales. |
| PCT/ES2010/070121 WO2010100310A1 (es) | 2009-03-06 | 2010-03-04 | Péptido para el tratamiento profiláctico o terapéutico de tumores de la piel en estadios iniciales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2011140477A true RU2011140477A (ru) | 2013-04-27 |
Family
ID=42709234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011140477/10A RU2011140477A (ru) | 2009-03-06 | 2010-03-04 | Пептид профилактического или терапевтического лечения опухолей кожи на начальных стадиях |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8658599B2 (enExample) |
| EP (1) | EP2404611A4 (enExample) |
| JP (1) | JP2012519671A (enExample) |
| CN (1) | CN102341115A (enExample) |
| AR (1) | AR075783A1 (enExample) |
| AU (1) | AU2010219857A1 (enExample) |
| BR (1) | BRPI1013363A8 (enExample) |
| CA (1) | CA2753461A1 (enExample) |
| ES (1) | ES2347627B1 (enExample) |
| MX (1) | MX2011009225A (enExample) |
| RU (1) | RU2011140477A (enExample) |
| TW (1) | TW201036625A (enExample) |
| WO (1) | WO2010100310A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014183018A2 (en) * | 2013-05-10 | 2014-11-13 | Southern Research Institute | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES THROUGH INHIBITING TGF-β ACTIVITY |
| CN110483648A (zh) * | 2019-08-27 | 2019-11-22 | 南京安吉生物科技有限公司 | 一种融合多肽及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2146552B1 (es) | 1998-11-24 | 2001-04-16 | Inst Cientifico Tecnol Navarra | Peptidos inhibidores de tgf/31 |
| EP1722823A2 (en) * | 2004-02-27 | 2006-11-22 | Antisense Pharma GmbH | Pharmaceutical composition |
| JP5112322B2 (ja) | 2005-10-24 | 2013-01-09 | プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ | 免疫応答調節剤の製造におけるＴＧＦ−β１インヒビターペプチドの使用 |
| BRPI0915093A2 (pt) * | 2008-06-13 | 2015-10-27 | Proyecto Biomedicina Cima Sl | conjugados para a administração de compostos biologicamente ativos |
-
2009
- 2009-03-06 ES ES200900694A patent/ES2347627B1/es not_active Expired - Fee Related
-
2010
- 2010-03-03 AR ARP100100633A patent/AR075783A1/es not_active Application Discontinuation
- 2010-03-04 BR BRPI1013363A patent/BRPI1013363A8/pt not_active IP Right Cessation
- 2010-03-04 AU AU2010219857A patent/AU2010219857A1/en not_active Abandoned
- 2010-03-04 CA CA2753461A patent/CA2753461A1/en not_active Abandoned
- 2010-03-04 US US13/255,059 patent/US8658599B2/en not_active Expired - Fee Related
- 2010-03-04 JP JP2011552477A patent/JP2012519671A/ja active Pending
- 2010-03-04 WO PCT/ES2010/070121 patent/WO2010100310A1/es not_active Ceased
- 2010-03-04 RU RU2011140477/10A patent/RU2011140477A/ru not_active Application Discontinuation
- 2010-03-04 CN CN2010800105516A patent/CN102341115A/zh active Pending
- 2010-03-04 EP EP10748370A patent/EP2404611A4/en not_active Withdrawn
- 2010-03-04 MX MX2011009225A patent/MX2011009225A/es not_active Application Discontinuation
- 2010-03-05 TW TW099106502A patent/TW201036625A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011009225A (es) | 2011-10-10 |
| CN102341115A (zh) | 2012-02-01 |
| WO2010100310A1 (es) | 2010-09-10 |
| BRPI1013363A8 (pt) | 2016-07-19 |
| TW201036625A (en) | 2010-10-16 |
| AR075783A1 (es) | 2011-04-27 |
| AU2010219857A1 (en) | 2011-10-06 |
| EP2404611A4 (en) | 2012-11-21 |
| ES2347627A1 (es) | 2010-11-02 |
| EP2404611A1 (en) | 2012-01-11 |
| BRPI1013363A2 (pt) | 2016-03-29 |
| CA2753461A1 (en) | 2010-09-10 |
| ES2347627B1 (es) | 2011-10-10 |
| US20120065144A1 (en) | 2012-03-15 |
| JP2012519671A (ja) | 2012-08-30 |
| US8658599B2 (en) | 2014-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
| MX2011011126A (es) | Composiciones y metodos para tratar quemaduras. | |
| SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| WO2009039397A3 (en) | Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer | |
| CL2012001056A1 (es) | Compuestos derivados de cromenona sustituidos, inhibidores de enzimas pi 3 quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion de trastornos de proliferacion celular, tales como tumores enfermedades inflamatorias y fibroticas, asma, diabetes insulinodependiente, entre otras. | |
| JOP20180009A1 (ar) | مركبات مثبط فيروس hiv | |
| EA201101507A1 (ru) | Способы лечения солидных опухолей | |
| EA201270824A1 (ru) | Соединения для уменьшения продукции бета-амилоида | |
| EA201101243A1 (ru) | 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств | |
| TW200744636A (en) | Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents | |
| DOP2011000055A (es) | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoxi-etil)-4-trifluorometoxi-1h-indol-3-il]-metanona como un inhibidor de la triptasa de mastocitos | |
| WO2016133903A3 (en) | Combination therapy for cancer treatment | |
| EA201071039A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
| RU2011108486A (ru) | ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ПЕПТИДА Wnt5-a ДЛЯ ЛЕЧЕНИЯ МЕЛАНОМЫ И РАКА ЖЕЛУДКА | |
| CO6612185A2 (es) | Composiciones famacéuticas para el tratamiento del cáncer y otras enfermedades o transtornos | |
| EA200870469A1 (ru) | Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение | |
| UA111599C2 (uk) | Композиція каспофунгіну | |
| PH12013500559A1 (en) | Combination therapy for treating hcv infection | |
| RU2010103781A (ru) | Противоопухолевые комбинации, содержащие ингибитор vegf и иринотекан | |
| RU2008148597A (ru) | Фармацевтические комбинации | |
| CR8603A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| EA201270747A1 (ru) | Композиции и способы для профилактики и лечения ран | |
| UA94036C2 (ru) | Фармацевтическая композиция бендамустина, предназначенная для лиофилизации | |
| RU2011140477A (ru) | Пептид профилактического или терапевтического лечения опухолей кожи на начальных стадиях | |
| MY156278A (en) | Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20141001 |